• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VYGON LEADER-CATH; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VYGON LEADER-CATH; INTRAVASCULAR CATHETER Back to Search Results
Model Number 115.090
Device Problems Fracture (1260); Material Fragmentation (1261)
Patient Problems Device Embedded In Tissue or Plaque (3165); No Code Available (3191)
Event Date 02/10/2020
Event Type  Injury  
Manufacturer Narrative
The failed sample will be returned to vygon for device evaluation as part of the complaint investigation.The results of this investigation are still pending, and will be communicated to fda within 30 days of its conclusion.The batch review of this batch shows that the product is compliant to its specification.The tensile strength is conform to iso norm.
 
Event Description
Patients artery scanned, device still in situ in radial artery, advice sort from vascular consultant.Patient review by vascular consultant (b)(6) 2020 due to the patients poor clinical condition no further action is required and the retention of the arterial line is unlikely to have a direct impact on the patient.The patient is frail and elderly post hemiarthroplasty surgery and has cognitive impairment with lack of ability to retain short term memory.The orthopaedic team have been asked to ensure that the retained of the part is clearly outlined within communication to the patients gp and the reason to leave the remaining part in situ.The patients nok have been spoken to and are aware of the impact to the patient and the advice offered from the vascular team.
 
Event Description
Patients artery scanned, device still in situ in radial artery, advice sort from vascular consultant.Patient review by vascular consultant (b)(6) 2020 due to the patients poor clinical condition no further action is required and the retention of the arterial line is unlikely to have a direct impact on the patient.The patient is frail and elderly post hemiarthroplasty surgery and has cognitive impairment with lack of ability to retain short term memory.The orthopaedic team have been asked to ensure that the retained of the part is clearly outlined within communication to the patients gp and the reason to leave the remaining part in situ.The patients nok have been spoken to and are aware of the impact to the patient and the advice offered from the vascular team.
 
Manufacturer Narrative
During the investigation, the reported fractured of the arterial line was confirmed.On examination under the microscope, a stretched and uneven aspect of the fracture surfaces was identified.From previous investigations, we are aware that these characteristics are associated with the occurrence of a tensile fracture having occurred.From the reporting form we understand that the incident occurred on the day of insertion.We would therefore recommend considering the possible causes of stress and flexion that may have been placed on the catheter (for example, movement of an extension set, during a dressing change).To prevent future reoccurrence of this issue, it may be worth considering the securement method used.Unfortunately, we are not aware of how the device was secured.The batch review of this batch shows that the product is compliant to its specification.The tensile strength is conform to iso norm.In evaluating our data registration system, we can confirm that we have not received any additional reports of a similar nature for the product code: 0115803 during 2019 and to date at 2020.This event seems not to be linked to a quality defect of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEADER-CATH
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
VYGON
5 rue adeline
ecouen 95440
FR  95440
MDR Report Key9762533
MDR Text Key181402359
Report Number2245270-2020-00011
Device Sequence Number1
Product Code DQO
Combination Product (y/n)N
PMA/PMN Number
K813142
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 07/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number115.090
Device Catalogue Number115.090
Device Lot Number8094298 OR 8095049
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 02/19/2020
Initial Date FDA Received02/27/2020
Supplement Dates Manufacturer Received02/19/2020
Supplement Dates FDA Received07/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-